Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1127956

O=C([O-])C(F)(F)F.O=C([O-])C(F)(F)F.[Co+2]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CA4 P22748 2/20 0.38
CA2 P00918 1/20 0.37
CA1 P00915 2/20 0.33
CASP1 P29466 1/20 0.33
FAHD1 Q6P587 1/20 0.33
ALDH1A1 P00352 1/20 0.30
POLB P06746 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5690375 0.96 CA4 (0.36) CA4CA2CA1CASP1FAHD1
Trifluoroacetic Acid SCHEMBL3275141 0.96 CA4 (0.36) CA4CA2CA1CASP1FAHD1
Trifluoroacetic Acid SCHEMBL31220183 0.96 CA4 (0.36) CA4CA2CA1CASP1FAHD1
Trifluoroacetic Acid SCHEMBL2381055 0.92 CA4 (0.38) CA4CA2CA1CASP1FAHD1
Trifluoroacetic Acid SCHEMBL20569310 0.92
Trifluoroacetic Acid SCHEMBL4398806 0.92
Trifluoroacetic Acid SCHEMBL20569660 0.92 CA4 (0.38) CA4CA2CA1CASP1FAHD1
Trifluoroacetic Acid SCHEMBL20571141 0.92 CA4 (0.38) CA4CA2CA1CASP1FAHD1
Trifluoroacetic Acid SCHEMBL20541013 0.92 CA4 (0.38) CA4CA2CA1CASP1FAHD1
Trifluoroacetic Acid SCHEMBL18797016 0.92 CA4 (0.38) CA4CA2CA1CASP1FAHD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119390625-A Preparation method of 1- (aryl sulfonyl) bicyclo [1.1.0] butane compound 苏州百灵威超精细材料有限公司 2025-02-07 CN claimed
EP-1560649-A4 ACTIVE CATALYSTS FOR STEREOSELECTIVE RING-OPENING REACTIONS RHODIA PHARMA SOLUTION INC (US) 2007-05-02 EP claimed
EP-1560649-A1 ACTIVE CATALYSTS FOR STEREOSELECTIVE RING-OPENING REACTIONS Rhodia Pharma Solution Inc. (US) 2005-08-10 EP claimed
US-6781006-B2 Active catalysts for stereoselective ring-opening reactions RHODIA PHARMA SOLUTIONS INC. 2004-08-24 US claimed
WO-2004026469-A1 ACTIVE CATALYSTS FOR STEREOSELECTIVE RING-OPENING REACTIONS RHODIA PHARMA SOLUTIONS INC. (US) 2004-04-01 WO claimed
US-20040053779-A1 Active catalysts for stereoselective ring-opening reactions SHASUN PHARMA SOLUTIONS, INC. 2004-03-18 US claimed
EP-0823441-B1 Cobalt containing catalyst system GOODYEAR TIRE & RUBBER (US) 2001-09-12 EP claimed
EP-0823441-A1 Cobalt containing catalyst system THE GOODYEAR TIRE & RUBBER COMPANY (US) 1998-02-11 EP claimed
CN-119390625-A Preparation method of 1- (aryl sulfonyl) bicyclo [1.1.0] butane compound 苏州百灵威超精细材料有限公司 2025-02-07 CN disclosed
CN-118702568-A Application of tetranuclear metal cluster catalyst in degradation and shrinkage cluster plastic 南京工业大学 2024-09-27 CN disclosed
EP-3195932-B1 HYDROSILYLATION REACTION CATALYST UNIV KYUSHU NAT UNIV CORP (JP) 2024-08-21 EP disclosed
EP-3181226-B1 HYDROSILYLATION REACTION CATALYST UNIV KYUSHU NAT UNIV CORP (JP) 2024-08-07 EP disclosed
EP-3856748-B1 METAL-ORGANIC FRAMEWORK PHASE AND CRYSTALLITE SHAPE CONTROL UNIV CALIFORNIA (US) 2024-03-06 EP disclosed
EP-3406616-B1 NOVEL ISOCYANIDE COMPOUND AND HYDROSILYLATION REACTION CATALYST SHINETSU CHEMICAL CO (JP) 2022-06-29 EP disclosed
EP-0936242-A1 Metal deactivator for cobalt catalyzed polymers THE GOODYEAR TIRE & RUBBER COMPANY (US) 1999-08-18 EP disclosed
EP-0823441-A1 Cobalt containing catalyst system THE GOODYEAR TIRE & RUBBER COMPANY (US) 1998-02-11 EP disclosed
EP-0482457-B1 Trans-1,4-polybutadiene synthesis GOODYEAR TIRE & RUBBER (US) 1997-05-14 EP disclosed
EP-0482457-A1 Trans-1,4-polybutadiene synthesis THE GOODYEAR TIRE & RUBBER COMPANY (US) 1992-04-29 EP disclosed
US-5089574-A TRANS-1,4-POLYBUTADIENE SYNTHESIS THE GOODYEAR TIRE & RUBBER COMPANY (US) 1992-02-18 US disclosed
US-4328379-A COBALT CATALYZED IN PRESENCE OF PERFLUOROCARBOXYLATE ANION EASTMAN KODAK COMPANY (US) 1982-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053779-A1 Active catalysts for stereoselective ring-opening reactions CROCC, CA1, NBAS CA4 96/4885CA2 82/4885CA1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.